SeaStar Medical Holding Corp. (LMAO) is a commercial-stage medical technology company based in Denver, CO, focused on developing therapies for critically ill patients experiencing organ failure, primarily utilizing its Selective Cytopheretic Device (SCD) therapy. Key executives and directors include CEO Eric Schlorff, Chief Medical Officer Kevin Chung, Chairman of the Board Jennifer A. Baird, and directors John Neuman, Bernadette N. Vincent, and Kenneth Van Heel. Insider trading activity for SeaStar Medical has shown a general pattern of buying by company insiders, with no reported insider stock sales since 2022. This indicates a trend where key individuals within the company, such as directors and the Chief Medical Officer, have been acquiring shares.
Join Stockcircle to see more insider trades and be the first to know about new executive transactions.
Sign UpTo improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.